What it takes to make an organ

What it takes to make an organ By Alison McCook Related Articles Betting on better organs Engineering an organ Two years ago, the first employees of Tengion walked into a 2,800 square meter warehouse in southeastern Pennsylvania that was full to the brim with office furniture, rising up to a 12-meter ceiling, and said: We'll take it. They cleared everything out and started to fill the empty space with rooms and equipment to automate something that had

Written byAlison McCook
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

By Alison McCook

Betting on better organs

Engineering an organ

Two years ago, the first employees of Tengion walked into a 2,800 square meter warehouse in southeastern Pennsylvania that was full to the brim with office furniture, rising up to a 12-meter ceiling, and said: We'll take it. They cleared everything out and started to fill the empty space with rooms and equipment to automate something that had never been automated before: human bladders.

The facility reflects the uniqueness of the company's efforts. In mid-September, the building, part of an office park, is surrounded by piles of dirt and rocks, with a Caterpillar earthmover, frozen in mid-scoop. Standing before an architectural blueprint, Jason Krentz, a former Marine who now directs manufacturing at Tengion, points to the different areas. Sections in blue, green, and pink surround a center yellow square - the "cleanest" part of the facility, where workers delicately handle ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies